8-K: Flora Growth Pivots to AI with Major Digital Asset Capital Raise

Flora Growth Corp. announced a significant strategic shift, divesting its cannabis business and raising over $400 million in cash and digital assets to fund a new digital asset treasury strategy focused on AI.

Summary

• Flora Growth Corp. is undergoing a major strategic pivot, divesting its entire hemp and cannabis-related business and raising approximately $401.84 million in capital through a series of private placements.
• The capital raise includes a Cash Private Placement generating approximately $13.66 million net proceeds from the sale of common shares and pre-funded warrants.
• A Token Private Placement secured approximately $215.3 million in net proceeds by issuing pre-funded warrants in exchange for 71,766,135 0G tokens, valued at $3.00 per token.
• A Note Private Placement raised approximately $22.88 million through an unsecured convertible note, paid for with 95,333.3333 Solana tokens, valued at $240 per Solana.
• An additional Zero Gravity Private Placement involved an unsecured convertible note for 50,000,000 0G tokens, valued at $150 million, which will replace a prior loan agreement and warrants if closed by October 22, 2025.
• The company disposed of its cannabis business, including 12 wholly-owned subsidiaries and a minority interest in Hoshi International Inc., to Flora Growth US Holdings LLC. This transaction satisfied $2.22 million in outstanding promissory notes.
• The fair market value of several divested cannabis subsidiaries (Vessel US, High Roller, Just, Just FL, Just International) was deemed zero as part of the disposition.
• New executive appointments include Daniel Reis-Faria as CEO and Michael Heinrich as Executive Chairman, both bringing expertise in AI and cybersecurity.
• Executive compensation packages include base salaries of $600,000 for the CEO and Executive Chairman, and $350,000 for the CFO, along with significant stock option grants (3% for CEO/Executive Chairman, 1.5% for CFO) exercisable at $27.20 per share, subject to shareholder approval and VWAP-based vesting.

Sentiment

Score: 7

Explanation: The company is undertaking a transformative strategic pivot with a substantial capital raise, which is generally positive for future growth potential. However, the divestiture of the core cannabis business at a potential loss and the inherent volatility and regulatory risks of digital assets introduce considerable uncertainty and execution risk. The new management team with AI expertise is a positive, but the success of the pivot is yet to be proven.

Positives

• Secured substantial capital of approximately $401.84 million, providing significant funding for new strategic initiatives.
• Strategic pivot towards high-growth sectors of digital assets and artificial intelligence, potentially unlocking new value streams.
• Appointment of new CEO Daniel Reis-Faria and Executive Chairman Michael Heinrich, both possessing strong backgrounds in AI and cybersecurity, which aligns with the new strategic direction.
• Streamlining of operations by divesting the cannabis business, allowing for a more focused allocation of resources on the new digital asset and AI strategy.
• The pre-funded warrants have a nominal exercise price of US$0.0001, indicating that the majority of the investment value is already paid upfront.

Negatives

• Divestiture of the entire hemp and cannabis-related business, which was the company's historical core, represents a complete shift away from its established market.
• The fair market value of several divested cannabis subsidiaries (Vessel US, High Roller, Just, Just FL, Just International) was explicitly stated as zero, indicating a significant write-down or loss on these assets.
• Shareholder approval is required for the issuance of warrant shares and conversion shares, introducing a contingency that could delay or prevent the full realization of the financing benefits.
• The company incurred a loss of $2.213 million on the forgiveness of intercompany loans as part of the cannabis business disposition.
• Potential for significant dilution for existing shareholders due to the issuance of common shares upon exercise of warrants and conversion of notes.

Risks

• Shareholder approval is a critical condition for the issuance of shares underlying the warrants and convertible notes, and failure to obtain it could impact the financing structure.
• The new digital asset treasury strategy is exposed to the inherent volatility and regulatory uncertainties of cryptocurrency markets (0G tokens, Solana).
• There is a risk of liquidated damages if the company fails to file or achieve effectiveness for resale registration statements within specified timelines, or if it fails to maintain public information requirements under Rule 144(c).
• The Zero Gravity Convertible Note agreement includes a covenant against market manipulation of 0G tokens, highlighting a recognized risk in the digital asset space.
• The company remains a guarantor for a real property lease in Winston Salem, North Carolina, related to the divested cannabis business, posing a potential ongoing liability.
• Successfully integrating a new digital asset treasury strategy and AI functionality into the company's business model presents operational and technological challenges.
• The company's operations in the digital asset and AI space are subject to evolving regulatory landscapes, including sanctions and anti-money laundering laws.

Future Outlook

The company intends to use the substantial capital raised to aggressively pursue a new digital asset treasury strategy, specifically linked to $0G, the native token of the 0G Chain, a layer-1 blockchain for decentralized AI applications. This includes exploring and expanding the use of the token's native AI functionality to enhance the company's business, with remaining proceeds allocated to general corporate and working capital purposes. The company is also seeking shareholder approval for a potential stock split and amendments to its incentive compensation plan to support this new direction.

Management Comments

• Daniel Reis-Faria's employment agreement acknowledges his continued involvement with other entities, provided it does not interfere with his responsibilities to Flora Growth Corp. and he devotes necessary time.
• The company acknowledges that investors are acting solely as arm's length investors and not as financial advisors or fiduciaries.
• The company's decision to enter into these agreements was based solely on its independent evaluation of the transactions.

Industry Context

This announcement marks a dramatic strategic pivot for Flora Growth Corp., shifting entirely away from the cannabis industry, which has faced significant regulatory challenges, market fragmentation, and pricing pressures. The move into digital assets and AI positions the company in two of the most dynamic and high-growth technology sectors. This transition reflects a broader trend of companies seeking to re-align their business models with emerging technological opportunities and investor interest in blockchain and AI innovations. The appointment of new leadership with deep expertise in these areas underscores the seriousness of this strategic reorientation.

Comparison to Industry Standards

• The strategic pivot from a traditional, regulated industry (cannabis) to emerging technology sectors (digital assets, AI) is a bold move, often seen in companies seeking to revitalize growth or escape challenging market conditions. This is comparable to other companies that have pivoted to capitalize on new technological waves, though the specific combination of digital assets and AI is distinct.
• The capital raise structure, utilizing a mix of cash, pre-funded warrants, and convertible notes, is a common financing mechanism for private placements, particularly for companies undergoing significant transformations or in early-stage high-growth sectors.
• The liquidated damages clauses for delays in registration statements (1.0% to 1.5% of subscription amount per 30 days) are standard investor protection provisions in private placement agreements, ensuring liquidity for investors in unregistered securities.
• The valuation of digital assets (0G tokens at $3.00, Solana at $240) for the purpose of these transactions is specific to the agreements and would need to be assessed against prevailing market rates for these cryptocurrencies at the time of closing to determine the attractiveness of the conversion terms relative to market benchmarks.
• The compensation structure for new executives, including substantial stock options with VWAP-based vesting, is designed to align management incentives with long-term shareholder value creation, a common practice in growth-oriented companies, especially in tech sectors.

Management Changes

Corporate Governance

Legal Proceedings

• The company entered into a confidential settlement and release agreement on August 11, 2025, to pay $1.8 million to a group representing the sellers of Just Brands LLC. In return, the plaintiffs will forfeit and waive any claim to company shares and release all known and unknown claims against the company.
• The Equity Transfer Agreement references 'Ongoing Litigation' as set forth in Flora's SEC filings, but no specific details of new or ongoing litigation are provided within this 8-K beyond the Just Brands settlement.

Related Party Transactions

• Clifford Starke (former CEO/Director, now CEO of Flora Growth US Holdings LLC) and other Noteholders contributed promissory notes with an aggregate outstanding balance of $2.22 million to Flora Growth US Holdings LLC in exchange for pro rata membership interests in that entity. This entity then received the cannabis business assets in full satisfaction of these notes.
• Daniel Reis-Faria (new CEO) participated as an investor in the Token Private Placement, contributing 50,000,000 0G Tokens (valued at $150 million) and receiving 5,954,743 Token Pre-funded Warrants.
• Michael Heinrich (new Executive Chairman) is the Chief Executive Officer of Zero Gravity Labs Inc., which contributed 50,000,000 0G Tokens (valued at $150 million) to the company in exchange for a Zero Gravity Convertible Note.
• Dany Vaiman (CFO) is a signatory on multiple agreements, including his own employment agreement and the company's agreements for the private placements and disposition.

Stakeholder Impact

• Shareholders face potential significant dilution from the issuance of new equity and a complete shift in the company's business model, introducing a new risk/reward profile. Shareholder approval is a key contingency for these transactions.
• Employees of the divested cannabis business will experience a change in ownership, potentially impacting their employment terms and conditions.
• Customers and suppliers of the cannabis business will now deal with Flora Growth US Holdings LLC, which may lead to changes in existing relationships and operations.
• Investors participating in the private placements gain exposure to the company's new digital asset and AI strategy, but are subject to market volatility, regulatory risks, and the need for shareholder approval for their securities to be fully issued and resalable.
• Creditors holding the promissory notes related to the cannabis business have had their debts satisfied through the disposition of those assets.

Next Steps

• Closing of the Cash, Token, Note, and Zero Gravity Private Placements is expected on or about September 26, 2025.
• The company will file a preliminary proxy statement seeking Shareholder Approval by October 24, 2025.
• The company aims to file the definitive proxy statement by November 10, 2025, if there is no SEC review.
• The Shareholder Meeting is targeted for January 6, 2026 (or January 9, 2026 for some notes) to approve the issuance of shares, a potential name change, stock split, and amendments to the Incentive Compensation Plan.
• If Shareholder Approval is not obtained, additional Shareholder Meetings will be held quarterly thereafter.
• The company will file resale registration statements on Form S-3 for the newly issued shares and warrant shares no later than six months after Shareholder Approval.
• Proceeds from the capital raise will be used to further the digital asset treasury strategy linked to the $0G token and expand its native AI functionality, with the balance for general corporate and working capital.

Key Dates

Recommendation

The company is undergoing a transformative strategic pivot from cannabis to digital assets and AI, backed by a substantial capital raise and new leadership with relevant expertise. While this shift targets high-growth sectors, it also introduces significant execution risk and exposure to volatile digital asset markets. The divestiture of the core cannabis business, with some assets valued at zero, indicates past underperformance in that segment. Investors should hold to observe the successful execution of this new strategy and the realization of value from the digital asset investments, as the long-term success is highly contingent on these unproven initiatives.

Keywords

Flora Growth Corp, Digital Assets, Artificial Intelligence, Capital Raise, Strategic Pivot, SEC Filing, 8-K, Private Placement, 0G Chain, Solana, Warrants, Convertible Notes, Cannabis Divestiture, Management Change, FLGC, Blockchain